A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of subcutaneous Mircera in the treatment of
renal anemia in patients with chronic kidney disease who are not on dialysis and not
receiving epoetin or any other erythropoietic substance. The anticipated time on study
treatment is 1-2 years and the target sample size is 100-500 individuals.